Hepatitis B/C in the countries of the EU/EEA: a systematic review of the prevalence among at-risk groups.
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Falla, Abby MayHofstraat, Sanne Henrietta Ina
Duffell, Erika
Hahné, Susan Josien Maria
Tavoschi, Lara
Veldhuijzen, Irene Karen
Type
ArticleLanguage
en
Metadata
Show full item recordTitle
Hepatitis B/C in the countries of the EU/EEA: a systematic review of the prevalence among at-risk groups.Published in
BMC Infect Dis 2018; 18(1):79Publiekssamenvatting
In 2016, the World Health Organisation set a goal to eliminate viral hepatitis by 2030. Robust epidemiological information underpins all efforts to achieve elimination and this systematic review provides estimates of HBsAg and anti-HCV prevalence in the European Union/European Economic Area (EU/EEA) among three at-risk populations: people in prison, men who have sex with men (MSM), and people who inject drugs (PWID).PMID
29433454ae974a485f413a2113503eed53cd6c53
10.1186/s12879-018-2988-x
Scopus Count
Collections